OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Kenneth W. Sigvardson is a director at The DuPont Pharmaceuticals Company, Experimental Station, PO Box 80353, Wilmington, DE 19880-0353.
October 02, 2001
A summary of the conclusions of the PhRMA Workshop on Acceptable Analytical Practices describes equipment qualification practices and guidelines that are designed to help the pharmaceutical industry be consistent in meeting core requirements.